More on CME

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+15.2% Growth)
- Ratings (4.0 Score)
- Holders
- Dividends (2% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/27/22)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CME Balance Sheet

Click line-items for a historical chart and %
Assets
Cash and cash equivalents 1.42B
Marketable securities 83.3M
Accounts receivable, net of allowance of $1.3 and $1.6 395.7M
Other current assets (includes $40.0 and $0 in restricted cash) 269.4M
Cash performance bonds and guaranty fund contributions 31.61B
Total current assets 33.78B
Property, net of accumulated depreciation and amortization of $556.5 and $512.9 426.7M
Intangible assets-trading products 17.18B
Intangible assets-other, net 2.47B
Goodwill 7.57B
Other assets (includes $20.0 and $0 in restricted cash) 1.84B
Total Assets 63.25B
Liabilities and Shareholders' Equity
Accounts payable 34.5M
Short-term debt
Other current liabilities 247M
Cash performance bonds and guaranty fund contributions 31.6B
Total current liabilities 31.89B
Long-term debt 2.23B
Deferred tax liabilities, net
Other liabilities 551.6M
Total Liabilities 41.99B
Redeemable non-controlling interest
Shareholders' Equity:
Preferred stock, $0.01 par value, 9,860 shares authorized, none issued or outstanding 0
Series A junior participating preferred stock, $0.01 par value, 140 shares authorized, none issued or outstanding
Additional paid-in capital 17.78B
Retained earnings 3.46B
Accumulated other comprehensive income (loss) 22.9M
Total Shareholders' Equity 21.26B
Total Liabilities and Shareholders' Equity 63.25B
Class A Common Stock [Member]
Shareholders' Equity:
Common stock 3.4M
Class B Common Stock [Member]
Shareholders' Equity:
Common stock 0